Patents by Inventor Jude Robert CANON

Jude Robert CANON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy including a KRASinhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
    Patent number: 11918584
    Abstract: The present invention provides combination therapy that includes an KRASG12C inhibitor, such as or a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
    Type: Grant
    Filed: July 21, 2022
    Date of Patent: March 5, 2024
    Assignee: Amgen Inc.
    Inventors: James Russell Lipford, Jude Robert Canon, Anne Y. Saiki, Karen Louise Rex
  • COMBINATION THERAPY INCLUDING A KRAS G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20230121955
    Abstract: The present invention provides combination therapy that includes an KRASG12C inhibitor, such as or a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
    Type: Application
    Filed: July 21, 2022
    Publication date: April 20, 2023
    Applicant: Amgen Inc.
    Inventors: James Russell LIPFORD, Jude Robert CANON, Anne Y. SAIKI, Karen Louise REX
  • Combination therapy including a KRASinhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
    Patent number: 11439645
    Abstract: The present invention provides combination therapy that includes an KRASG12C inhibitor, such as or a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: September 13, 2022
    Assignee: Amgen Inc.
    Inventors: James Russell Lipford, Jude Robert Canon, Anne Y. Saiki, Karen Louise Rex
  • COMBINATION THERAPY INCLUDING A KRAS G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20200222407
    Abstract: The present invention provides combination therapy that includes an KRASG12C inhibitor, such as or a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
    Type: Application
    Filed: November 18, 2019
    Publication date: July 16, 2020
    Inventors: James Russell LIPFORD, Jude Robert CANON, Anne Y. SAIKI, Karen Louise REX